• Mitsui Chemicals' 2026 annual report outlines accelerated restructuring of Basic & Green Materials, with a business split planned for fiscal 2027.
• Persistent losses in basic materials remain a priority as specialty chemicals earnings growth trails expectations.
• Decisions on underperforming businesses are due by fiscal 2026-end, while growth investment will focus on healthcare and ICT.
• Ethylene facility consolidation targets eastern Japan in 2027 and western Japan in 2030 through partnerships.
• The acquisition of Ultradent Products establishes a US healthcare platform, with growth opportunities in preventive dentistry.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mitsui Chemicals Inc. published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.